Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02106-0002-0000-3 |
Chemical Name: | Ellagic acid |
CASRN: | 476-66-4 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 417915_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Positive |
Induced Rat Liver S9 | 1_S9 | Negative |
No Activation | 2 | Positive |
Induced Rat Liver S9 | 2_S9 | Negative |
No Activation | 3 | Positive |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 5 | 0.025 | 2.0 | 1 | 0.005 | 0.5 | 4 | 0.020 | 1.5 | 0 | 0.000 | 0.0 |
Medium | 0 | 200 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Ellagic acid | 60 | 200 | 13 | 0.065 | 4.5 | 0 | 0.000 | 0.0 | 13 | 0.065 | 4.5 | 0 | 0.000 | 0.0 |
79.5 | 200 | 36 | 0.180 | 10.5 | 0 | 0.000 | 0.0 | 36 | 0.180 | 10.5 | 0 | 0.000 | 0.0 | ||
100 | 10 | 39 | 3.900 | 100.0 | 16 | 1.600 | 80.0 | 23 | 2.300 | 80.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 200 | 56 | 0.280 | 15.5 | 30 | 0.150 | 10.5 | 26 | 0.130 | 8.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 12 | 0.480 | 32.0 | 4 | 0.160 | 16.0 | 8 | 0.320 | 20.0 | 0 | 0.000 | 0.0 | |
Trend: | 6.914 | 6.206 | 6.359 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 4 | 0.020 | 2.0 | 1 | 0.005 | 0.5 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
Medium | 0 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | |
Test Chemical: | Ellagic acid | 50 | 200 | 3 | 0.015 | 1.5 | 2 | 0.010 | 1.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
100 | 200 | 5 | 0.025 | 2.5 | 0 | 0.000 | 0.0 | 5 | 0.025 | 2.5 | 0 | 0.000 | 0.0 | ||
150 | 200 | 14 | 0.070 | 4.0 | 1 | 0.005 | 0.5 | 13 | 0.065 | 4.0 | 0 | 0.000 | 0.0 | ||
200 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 6.25 | 200 | 17 | 0.085 | 8.5 | 4 | 0.020 | 2.0 | 13 | 0.065 | 6.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 12.5 | 25 | 10 | 0.400 | 28.0 | 4 | 0.160 | 16.0 | 6 | 0.240 | 20.0 | 0 | 0.000 | 0.0 | |
Trend: | 2.493 | 0.097 | 2.938 | ||||||||||||
Probability: | 0.006 | 0.461 | 0.002 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 200 | 1 | 0.005 | 0.5 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Ellagic acid | 60 | 200 | 10 | 0.050 | 4.0 | 1 | 0.005 | 0.5 | 9 | 0.045 | 4.0 | 0 | 0.000 | 0.0 |
70.2 | 200 | 10 | 0.050 | 5.0 | 4 | 0.020 | 2.0 | 6 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
80 | 200 | 13 | 0.065 | 6.0 | 9 | 0.045 | 4.0 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
90 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 200 | 18 | 0.090 | 7.0 | 11 | 0.055 | 4.5 | 7 | 0.035 | 3.5 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 14 | 0.560 | 40.0 | 5 | 0.200 | 20.0 | 9 | 0.360 | 32.0 | 0 | 0.000 | 0.0 | |
Trend: | 2.858 | 2.893 | 1.046 | ||||||||||||
Probability: | 0.002 | 0.002 | 0.148 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 200 | 4 | 0.020 | 2.0 | 1 | 0.005 | 0.5 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 | |
Test Chemical: | Ellagic acid | 150 | 200 | 4 | 0.020 | 2.0 | 1 | 0.005 | 0.5 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
200 | 200 | 5 | 0.025 | 2.5 | 1 | 0.005 | 0.5 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
250 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 200 | 24 | 0.120 | 11.5 | 8 | 0.040 | 4.0 | 16 | 0.080 | 7.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 13 | 0.520 | 36.0 | 7 | 0.280 | 24.0 | 6 | 0.240 | 20.0 | 0 | 0.000 | 0.0 | |
Trend: | -0.907 | -0.749 | -0.627 | ||||||||||||
Probability: | 0.818 | 0.773 | 0.735 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Medium | 0 | 100 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Ellagic acid | 70.2 | 100 | 18 | 0.180 | 7.0 | 0 | 0.000 | 0.0 | 18 | 0.180 | 7.0 | 0 | 0.000 | 0.0 |
80 | 100 | 17 | 0.170 | 11.0 | 2 | 0.020 | 2.0 | 15 | 0.150 | 10.0 | 0 | 0.000 | 0.0 | ||
90 | 100 | 19 | 0.190 | 15.0 | 1 | 0.010 | 1.0 | 18 | 0.180 | 14.0 | 0 | 0.000 | 0.0 | ||
100 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 100 | 36 | 0.360 | 22.0 | 15 | 0.150 | 12.0 | 21 | 0.210 | 14.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 33 | 1.320 | 68.0 | 16 | 0.640 | 48.0 | 17 | 0.680 | 44.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.400 | 1.323 | 3.164 | ||||||||||||
Probability: | 0.000 | 0.093 | 0.001 |